Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche rejoins ABPI after six-month suspension

February 23, 2009
Sales and Marketing Code of Practice, Roche

Roche has been allowed to rejoin the ranks of the ABPI, after its six-month suspension for bringing discredit on the …

News

Shire acquires ADHD presence in Europe

February 23, 2009
Sales and Marketing ADHD, Shire

Shire has bought the global rights for two established treatments for Attention Deficit Hyperactivity Disorder from UCB. The acquisition gives …

News

CV Therapeutics rejects Astellas takeover bid

February 23, 2009
Sales and Marketing Astellas, CV Therapeutics

Biotech company CV Therapeutics has rejected a second take-over offer from Astellas, saying the Japanese group failed to recognise its …

News

The Pharmafocus interview: Simon Jose

February 20, 2009
Sales and Marketing GlaxoSmithKline, Simon Jose, UK, partnerships, pricing

Like all his contemporaries in the UK, Simon Jose, GlaxoSmithKline’s head of UK   operations has to focus on some of …

Feature

Raptiva suspended in Europe over safety concerns

February 20, 2009
Research and Development, Sales and Marketing Europe, Rapitva

Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …

News

Servier claims victory over NICE in osteoporosis

February 19, 2009
Research and Development, Sales and Marketing NICE, Servier

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …

News

GSK’s diabetes candidate enters phase III

February 19, 2009
Research and Development GSK, diabetes

A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …

News

Anger over private firm’s role in prescribing controls

February 19, 2009
NHS

Pharmacy and GP representatives have attacked plans for a private company to oversee primary care prescribing costs.Private provider Assura is …

News

Sanofi-Aventis joins YouTube revolution

February 18, 2009
Sales and Marketing Sanofi-Aventis, diabetes

Sanofi-Aventis has launched its first YouTube channel, aimed at diabetes sufferers in the US.Reached by typing the keyword goinsulin into …

News

Genzyme says new plant approval is imminent

February 18, 2009
Research and Development, Sales and Marketing Genzyme

Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …

News

Novartis and charity team up on AMD campaign

February 18, 2009
Medical Communications, Sales and Marketing AMD, ophthalmology

Novartis has teamed up with blindness charity the RNIB on a new campaign to promote awareness of age-related macular degeneration …

News

Lilly to boost biotech stake in NeuroSearch deal

February 17, 2009
Research and Development Denmark, Europe, NeuroSearch

Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …

News

Pharma needs fresh ideas from outside industry, says Barker

February 17, 2009
Research and Development, Sales and Marketing ABPI, strategy

Pharma must re-invent itself and inject new ideas into its business model by hiring talented people from outside the sector, …

News

Positive results halt Avastin-Tarceva trial

February 16, 2009
Sales and Marketing Cancer, Roche, avastin

A phase III trial has been stopped early after promising results for Avastin and Tarceva combined as first-line maintenance treatment …

News

GSK: renewing the HIV pipeline

February 16, 2009
Research and Development GSK, HIV

GlaxoSmithKline and Idenix are to co-develop IDX899 for the treatment of HIV infection. Despite having eight marketed HIV products, GSK …

News

Managers need training too

February 13, 2009
Business Services management, recruitment, training

Most of us recognise that personal training and development is an essential requirement for successful career advancement, but for many …

Feature

Working Life: Kay Spiller

February 13, 2009
Sales and Marketing Astellas Pharma Europe, marketing

How did you find your way into your role? This was really through what I would describe as the 'traditional' …

Feature

Bayer’s cardiovascular drug enters phase III

February 13, 2009
Research and Development, Sales and Marketing Bayer, cv

Bayer Schering Pharma has begun phase III trials of riociguat for treatment of two life-threatening conditions. Two trials will investigate …

News

Patient surveys to be a world first for NHS

February 13, 2009
Sales and Marketing NHS, PROMs, hc

Patients who have a hip replacements or varicose vein surgery on the NHS will be among the first patients to …

News

Viehbacher sets out vision for diversified Sanofi-Aventis

February 11, 2009
Sales and Marketing Sanofi

Sanofi-Aventis's new chief executive Chris Viehbacher has presented his vision to renew the company, which will include greater investment in …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026